This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (16)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Metabolic Diseases  • Obesity  • Alert me on articles by topic

Arch Intern Med. 2003;163:395-397.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

TWO RECENT EVENTS have focused the attention of the medical community on the metabolic syndrome: (1) the inclusion of the syndrome in the recently published Adult Treatment Panel III (ATPIII) guidelines of the National Cholesterol Education Program,¹ and (2) the creation of an International Classification of Diseases, Ninth Revision diagnostic code, 277.7, which makes reimbursement for treating the syndrome possible. This syndrome, also called dysmetabolic syndrome, syndrome X, and the insulin resistance syndrome, has been the subject of numerous scientific studies. Now momentum is growing to translate knowledge gained from these basic and clinical research studies into day-to-day clinical practice.

In this issue of the ARCHIVES, Park et al² extend the initial analysis by Ford et al,³ who reported that more than 20% of participants in the third National Health and Nutrition Examination Survey (NHANES III) have the metabolic syndrome. Park et al,² using the same database, describe how prevalence . . . [Full Text of this Article]

AGE AND OBESITY AS KEY PREDICTORS


ETHNICITY AND THE METABOLIC SYNDROME

WHAT TO DO?

EVALUATION

WHEN TO INTERVENE?

HOW TO INTERVENE
Lifestyle Modification

Insulin-Sensitizing Drugs

Weight Loss Drugs

Drugs for Heart Disease Prevention

RELATED ARTICLE

The Metabolic Syndrome: Prevalence and Associated Risk Factor Findings in the US Population From the Third National Health and Nutrition Examination Survey, 1988-1994
Yong-Woo Park, Shankuan Zhu, Latha Palaniappan, Stanley Heshka, Mercedes R. Carnethon, and Steven B. Heymsfield
Arch Intern Med. 2003;163(4):427-436.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The metabolic syndrome and the risk of thrombosis
Dentali et al.
haematol 2007;92:297-299.
FULL TEXT  

Clinical Use of the Metabolic Syndrome: Why the Confusion?
Blaha and Elasy
Clin. Diabetes 2006;24:125-131.
ABSTRACT | FULL TEXT  

Bezafibrate for the Secondary Prevention of Myocardial Infarction in Patients With Metabolic Syndrome
Tenenbaum et al.
Arch Intern Med 2005;165:1154-1160.
ABSTRACT | FULL TEXT  

Effect of Metabolic Syndrome on Heart Attack and Mortality in Mexican-American Elderly Persons: Findings of 7-Year Follow-Up From the Hispanic Established Population for the Epidemiological Study of the Elderly
Otiniano et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2005;60:466-470.
ABSTRACT | FULL TEXT  

Hyperinsulinemia and risk of Alzheimer disease
Luchsinger et al.
Neurology 2004;63:1187-1192.
ABSTRACT | FULL TEXT  

Metabolic syndrome: Waist not want not
Weir and Lipscombe
CMAJ 2004;170:1390-1391.
FULL TEXT  

The Metabolic Syndrome: All Criteria Are Equal, but Some Criteria Are More Equal Than Others
Giannini and Testa
Arch Intern Med 2003;163:2787-2788.
FULL TEXT  

Increased Dietary Fat Attenuates the Anorexic Effects of Intracerebroventricular Injections of MTII
Clegg et al.
Endocrinology 2003;144:2941-2946.
ABSTRACT | FULL TEXT